Showing results (451-460 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|June 22, 1999
Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern PortugalS Alves, M J Prata, F Ferreira, et al.Pharmacogenetics|September 2, 1999
A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotypeM Chida, T Yokoi, N Nemoto, et al.Pharmacogenetics|September 2, 1999
Human nicotinamide N-methyltransferase pharmacogenetics: gene sequence analysis and promoter characterizationL Yan, D M Otterness, R M WeinshilboumPharmacogenetics|September 2, 1999
Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutationsA Kaneko, Y Bergqvist, G Taleo, et al.Pharmacogenetics|September 2, 1999
In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activityA Rostami-Hodjegan, H K Kroemer, G T TuckerPharmacogenetics|January 14, 2000
Involvement of CYP2D6 activity in the N-oxidation of procainamide in manE Lessard, B A Hamelin, L Labbé, et al.Pharmacogenetics|January 14, 2000
Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery diseaseI Cascorbi, M Laule, P M Mrozikiewicz, et al.Pharmacogenetics|April 20, 1999
Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptorM Brüss, H Bönisch, M Bühlen, et al.Pharmacogenetics|April 20, 1999
Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1D Siegel, S M McGuinness, S L Winski, et al.Pharmacogenetics|June 1, 1995
Polymorphisms of human Ah receptor gene are not involved in lung cancerK Kawajiri, J Watanabe, H Eguchi, et al.Pageof 83